The Senior Director, External Innovation owns external innovation strategy and execution for one or more designated therapeutic or disease areas within Neuroscience, such as neurodegeneration, pain, psychiatry/psychedelics, or sleep-wake. The role leads partnering projects independently from opportunity identification through scientific due diligence, recommendation, and deal completion. It translates strategic theses into deal constructs and serves as the scientific point of contact for partners, combining deep scientific and technical judgment with business and deal-structuring expertise. The role may mentor or directly supervise more junior External Innovation colleagues. External Innovation supports Lilly’s portfolio strategy through identification, rigorous evaluation, and advancement of external opportunities. Neuroscience opportunities may include research collaborations, platform and asset licenses, equity investments, and acquisitions involving private or public companies and modalities such as small molecules, antibodies, oligonucleotides, gene therapies, and blood–brain barrier delivery technologies. The position develops external strategy and search priorities in collaboration with senior management; identifies and evaluates opportunities; leads scientific due diligence and partner interactions; develops initial deal constructs; aligns internal stakeholders; and works with cross-functional colleagues to advance, negotiate, and transition deals. It represents external innovation for the assigned area in internal governance and external forums, maintains knowledge of scientific and competitive developments, and supports junior colleagues on deals.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior